About Us – Progenics Laboratories Pvt Ltd

Who We are

Personalised and precision medicine is an emerging healthcare model which aims at customised prevention and more effective treatment strategies. Next generation sequencing is a powerful tool to power up personalised treatments and improve the prognosis of many chronic diseases and syndromes. Progenics is not just equipped with high throughput machinery but also with a team of experienced scientists and bioinformaticians. Progenics provide better insights on the interpretation of genotype and phenotype interactions.

Who We are

Progenics

Our Vision

To be the Global Leader in Providing Genomic Services and Solutions, we provide customers from around the world with first-class services and solutions; achieve international recognition and become a technology leader and a world class company providing an excellent customer experience.

About our team

Progenics: Acclaimed Scientific Expertise in Genetic Diagnostics.

At Progenics, our scientific, informatics, and technical staff possess exceptional knowledge and extensive experience in the field of genetic diagnostics. Our team is comprised of highly skilled professionals who have garnered recognition both nationally and internationally. With a shared passion for excellence, we are driven to deliver the finest genetic diagnostic services, ensuring the utmost accuracy and precision for our valued patients.

Importance of genetic testing in post COVID era

Recent studies are showing that the willingness to perform genetic tests has noticeably increased in the post-COVID era (Deruelle T et al; 2023). Globally cardiovascular diseases (CVDs) are the leading cause of death and it is very much important to detect CVDs as early as possible for the better management of the disease and studying the inheritance patterns. CVDs can be monogenic or polygenic. While the COVID-19 pandemic continues to impact the world in 2023, another significant global health challenge persists—cardiovascular diseases (CVDs). The intersection of the COVID era and the prevalence of CVDs has highlighted the importance of innovative approaches to cardiovascular health management. Progenic, a leading genetic testing platform, is at the forefront of advancing our understanding of genetic factors associated with CVDs. This article explores how Progenic's genetic testing is playing a pivotal role in enhancing cardiovascular disease management in the global COVID era of 2023.